SCHEMBL5013244

SCHEMBL5013244

Cc1nc2c(ccc3[nH]cc(C4CN5CCC4CC5)c32)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.41
NOS3 P29474 3/20 0.38
NOS1 P29475 3/20 0.38
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
NOS2 P35228 1/20 0.35
CHRNA7 P36544 1/20 0.35
HTR1D P28221 2/20 0.34
HTR1B P28222 2/20 0.34
HTR1F P30939 2/20 0.34
TLR9 Q9NR96 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE1C Q14123 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5011654 0.99 HTR1A (0.41) HTR1ANOS3NOS1CYP3A4CYP2C19
SCHEMBL5013261 0.84 NOS3 (0.37) HTR1ANOS3NOS1CYP3A4CYP2C19
SCHEMBL5013240 0.82 CHRNA7 (0.40) NOS3NOS1CHRNA7
Hydrochloric Acid SCHEMBL5011631 0.81 CHRNA7 (0.39) NOS3NOS1CYP3A4CYP2C19NOS2
SCHEMBL5011676 0.81 NOS3 (0.34) HTR1ANOS3NOS1CYP3A4CYP2C19
SCHEMBL5657650 0.81 NOS3 (0.36) NOS3NOS1CYP3A4CYP2C19NOS2
SCHEMBL3548801 0.81 NOS3 (0.38) NOS3NOS1CYP3A4CYP2C19NOS2
Hydrochloric Acid SCHEMBL5013243 0.80 NOS3 (0.33) HTR1ANOS3NOS1CYP3A4CYP2C19
Hydrochloric Acid SCHEMBL5656615 0.80 NOS3 (0.36) NOS3NOS1CYP3A4CYP2C19NOS2
Hydrochloric Acid SCHEMBL3545242 0.80 NOS3 (0.38) NOS3NOS1CYP3A4CYP2C19NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383774-B1 DIHYDROIMIDAZO¬4,5-E INDOLE AND 7H-PYRROLO¬3,2-F QUINOXALINE DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND/OR SEROTONERGIC LIGANDS MERCK PATENT GMBH (DE) 2008-05-07 EP disclosed
US-7279496-B2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands MERCK PATENT GMBH (DE) 2007-10-09 US disclosed
US-20040142935-A1 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands MERCK PATENT GMBH (DE) 2004-07-22 US disclosed
EP-1383774-A2 DIHYDROIMIDAZO[4,5-E]INDOLE AND 7H-PYRROLO[3,2-F]QUINOXALINE DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND/OR SEROTONERGIC LIGANDS MERCK PATENT GmbH (DE) 2004-01-28 EP disclosed
WO-2002088143-A2 DIHYDROIMIDAZO[4,5-E]INDOLE AND 7H-PYRROLO[3,2-F]QUINOXALINE DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND/OR SEROTONERGIC LIGANDS MERCK PATENT GMBH (DE) 2002-11-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142935-A1 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands CHRNA5, HTR5A, CHRNA4 HTR1A 4/4885NOS3 1750/4885NOS1 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.